α
AlphaScala
StocksSignalsNEWAlpha ScoreBrokers
Sign InGet Started
α
AlphaScala

Professional trading analysis with publicly tracked portfolios on TipRanks. Real trades, real data.

Markets

ForexStocksCryptoCommodities

Tools

Stock ResearchMarket SignalsAlpha ScoreHedge Funds 13FInsider BuysAgentic TradingAI Broker MatcherBroker ReviewsPortfoliosFree IndicatorsBlogLearn TradingTrading Q&A

Account

Sign InDashboardNewsletterContact UsAdvertise

Legal

AboutEditorial PolicyCorrectionsTerms of ServicePrivacy PolicyRisk Disclaimer

Risk Warning: AlphaScala provides educational content only and is not a financial advisor. Trading and investing involves substantial risk of loss and is not suitable for all investors. Past performance does not guarantee future results. You should consult a licensed financial advisor before making investment decisions. See our full risk disclaimer.

For AI AgentsAlphaScala is agent-ready —skill.md·llms.txt
© 2026 ROGA AI LIMITED · Registered in Gibraltar · Unit G02, Eurocity, Europort Avenue, Gibraltar GX11 1AAAlphaScala — Built with data, not hype.
All Stocks/Healthcare/TECH

BIO-TECHNE Corp

TECH
HealthcareBiotechnology Website
Signal SnapshotMarket signals →
Alpha Score
Score pending
Alpha Score appears once the required price and fundamentals data has ingested.
Daily model
Insiders
No recent signal
No recent open-market insider buying or selling is in the current rollup.
Form 4
13F Holder
Maverick Capital
$226.47M reported position; latest action: new.
Lee Ainslie
Latest Filing
No filing digest
Recent 10-K, 10-Q, and 8-K summaries will appear here when available.
SEC digest
Price ChartPowered by TradingView
Ask about TECHAI research agent
Top Institutional HoldersFrom 13F filings
FundShares HeldPosition ValueAction (latest Q)
Maverick Capital
Lee Ainslie
3.85M$226.47MNEW
Citadel
Ken Griffin
984K$57.89MNEW
Marshall Wace18K$1.08MNEW
Explore all tracked funds →
About BIO-TECHNE Corp

Bio-Techne Corporation is a global developer, manufacturer and supplier of high-quality reagents, analytical instruments, and precision diagnostics serving the research, diagnostic, and bioprocessing markets worldwide. The company operates through two primary segments: protein sciences, which develops biological reagents including cytokines, growth factors, antibodies, and cell selection technologies; and diagnostics and spatial biology, which provides diagnostic reagents, molecular diagnostics, and spatial biology products. Bio-Techne maintains an extensive catalog of over 500,000 products, with approximately 95% manufactured in-house. Its portfolio includes flagship brands such as R&D Systems, Novus Biologicals, ProteinSimple, Advanced Cell Diagnostics, Asuragen, and Tocris Bioscience, serving academic research institutions, pharmaceutical and biotechnology companies, clinical diagnostic laboratories, and government agencies. Headquartered in Minneapolis, Minnesota, the company operates manufacturing facilities, research centers, and customer support offices across North America, Europe, and Asia-Pacific, generating significant revenue from the United States while maintaining a strong international presence. Bio-Techne's reputation for high-quality proteomic reagents and instruments enables it to maintain strong margins and cash flow while supporting scientific discovery and clinical breakthroughs.

CEO
Mr. Kim Kelderman
Employees
3,100
Quick Facts
Exchange—
SectorHealthcare
IndustryBiotechnology
Market Cap—
Popular Stocks
AAPL
Apple Inc.
MSFT
Microsoft Corporation
NVDA
NVIDIA Corporation
AMZN
Amazon.com Inc.
GOOGL
Alphabet Inc. Class A
GOOG
Alphabet Inc. Class C
META
Meta Platforms Inc.
TSLA
Tesla Inc.
Key Dates

Earnings calendar coming soon. Subscribe to get notified when TECH reports next.

Get earnings alerts →